• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    ChemoCentryx, Inc. (CCXI)

    -NasdaqGS
    7.49 Down 0.14(1.83%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.63
    Open:7.59
    Bid:N/A
    Ask:8.20 x 200
    1y Target Est:13.00
    Beta:0.87
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:7.29 - 7.70
    52wk Range:4.06 - 9.20
    Volume:147,315
    Avg Vol (3m):114,173
    Market Cap:327.27M
    P/E (ttm):N/A
    EPS (ttm):-1.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CCXIDown 1.83%327.27M
    ABTDown 0.63%72.99B
    AMGNDown 0.16%124.37B
    AZNDown 0.59%87.78B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.13
    Quarterly EPS Est (Jun-15) :-0.28
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback